Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipocytes | 2 | 2020 | 273 | 0.980 |
Why?
|
| Stem Cells | 2 | 2018 | 276 | 0.780 |
Why?
|
| Thermogenesis | 1 | 2020 | 127 | 0.580 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 171 | 0.540 |
Why?
|
| Adipogenesis | 1 | 2018 | 81 | 0.500 |
Why?
|
| Endothelial Cells | 2 | 2021 | 208 | 0.470 |
Why?
|
| Adipocytes, White | 1 | 2012 | 27 | 0.350 |
Why?
|
| Adipocytes, Brown | 1 | 2012 | 46 | 0.350 |
Why?
|
| Adipose Tissue | 1 | 2012 | 299 | 0.300 |
Why?
|
| Atrial Fibrillation | 3 | 2022 | 879 | 0.290 |
Why?
|
| Ketones | 1 | 2006 | 6 | 0.250 |
Why?
|
| Models, Biological | 1 | 2012 | 1192 | 0.250 |
Why?
|
| Heme Oxygenase-1 | 1 | 2021 | 19 | 0.180 |
Why?
|
| Telomerase | 1 | 2021 | 30 | 0.180 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 36 | 0.180 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2021 | 28 | 0.170 |
Why?
|
| Wearable Electronic Devices | 1 | 2022 | 76 | 0.170 |
Why?
|
| Perilipin-1 | 1 | 2020 | 11 | 0.160 |
Why?
|
| Atrial Remodeling | 1 | 2020 | 23 | 0.160 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2020 | 7 | 0.160 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2020 | 52 | 0.160 |
Why?
|
| Uncoupling Protein 1 | 1 | 2020 | 51 | 0.160 |
Why?
|
| Lipid Droplets | 1 | 2020 | 35 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 1 | 2019 | 12 | 0.150 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2019 | 17 | 0.150 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2019 | 45 | 0.150 |
Why?
|
| Pericardium | 1 | 2019 | 35 | 0.150 |
Why?
|
| Cell Communication | 1 | 2020 | 133 | 0.150 |
Why?
|
| Hindlimb | 1 | 2019 | 54 | 0.150 |
Why?
|
| Intra-Abdominal Fat | 1 | 2019 | 36 | 0.150 |
Why?
|
| Oxygen Consumption | 1 | 2020 | 213 | 0.150 |
Why?
|
| Cells, Cultured | 2 | 2021 | 2188 | 0.150 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2020 | 70 | 0.150 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 169 | 0.140 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 179 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 138 | 0.140 |
Why?
|
| Ischemia | 1 | 2019 | 203 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 3485 | 0.130 |
Why?
|
| Energy Metabolism | 1 | 2020 | 399 | 0.130 |
Why?
|
| Aorta | 1 | 2018 | 108 | 0.130 |
Why?
|
| Cell Nucleus | 1 | 2020 | 630 | 0.120 |
Why?
|
| Mice | 4 | 2021 | 11119 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2019 | 324 | 0.120 |
Why?
|
| Membrane Proteins | 1 | 2021 | 919 | 0.120 |
Why?
|
| Transcriptome | 1 | 2018 | 399 | 0.100 |
Why?
|
| Male | 7 | 2022 | 31047 | 0.100 |
Why?
|
| Phenotype | 1 | 2018 | 1233 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2020 | 713 | 0.100 |
Why?
|
| Neurons | 1 | 2019 | 933 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 1630 | 0.100 |
Why?
|
| Stroke | 1 | 2022 | 1211 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 731 | 0.100 |
Why?
|
| Galactosides | 1 | 2012 | 3 | 0.090 |
Why?
|
| Aged | 4 | 2022 | 14965 | 0.090 |
Why?
|
| Pericytes | 1 | 2012 | 17 | 0.090 |
Why?
|
| Obesity | 1 | 2020 | 1274 | 0.090 |
Why?
|
| Cadherins | 1 | 2012 | 90 | 0.090 |
Why?
|
| Microscopy, Electron | 1 | 2012 | 254 | 0.090 |
Why?
|
| Indoles | 1 | 2012 | 112 | 0.090 |
Why?
|
| Animals | 4 | 2021 | 21345 | 0.090 |
Why?
|
| Humans | 9 | 2022 | 65140 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2012 | 342 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2012 | 282 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 624 | 0.080 |
Why?
|
| Regional Blood Flow | 2 | 2021 | 116 | 0.080 |
Why?
|
| Female | 6 | 2022 | 34018 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2012 | 663 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 5614 | 0.080 |
Why?
|
| Young Adult | 1 | 2020 | 4809 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 896 | 0.080 |
Why?
|
| Middle Aged | 3 | 2020 | 18273 | 0.070 |
Why?
|
| Rats | 1 | 2012 | 1994 | 0.070 |
Why?
|
| Echocardiography | 2 | 2020 | 510 | 0.060 |
Why?
|
| Acetic Anhydrides | 1 | 2006 | 1 | 0.060 |
Why?
|
| Anhydrides | 1 | 2006 | 1 | 0.060 |
Why?
|
| Phenylacetates | 1 | 2006 | 3 | 0.060 |
Why?
|
| Acetic Acid | 1 | 2006 | 10 | 0.060 |
Why?
|
| Imidazoles | 1 | 2006 | 82 | 0.060 |
Why?
|
| Catalysis | 1 | 2006 | 164 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2006 | 316 | 0.060 |
Why?
|
| Amino Acids | 1 | 2006 | 148 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 1225 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2012 | 1556 | 0.050 |
Why?
|
| Adult | 1 | 2020 | 17358 | 0.050 |
Why?
|
| Photoplethysmography | 1 | 2022 | 38 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2022 | 99 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2021 | 45 | 0.040 |
Why?
|
| Artifacts | 1 | 2022 | 126 | 0.040 |
Why?
|
| Stress, Mechanical | 1 | 2021 | 117 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 84 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 129 | 0.040 |
Why?
|
| Heart Rate | 1 | 2022 | 331 | 0.040 |
Why?
|
| Atrial Function, Left | 1 | 2020 | 32 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2020 | 129 | 0.040 |
Why?
|
| Self Report | 1 | 2022 | 390 | 0.040 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2019 | 9 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2022 | 554 | 0.040 |
Why?
|
| Subcutaneous Fat | 1 | 2019 | 50 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2019 | 212 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2019 | 297 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2019 | 542 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2020 | 267 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2022 | 525 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1050 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1282 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 730 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2021 | 2157 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 794 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2022 | 2102 | 0.030 |
Why?
|
| Exercise | 1 | 2022 | 964 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 3308 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 1480 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2620 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 788 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 5429 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 6872 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 3153 | 0.020 |
Why?
|